Scalp Psoriasis Treatment Guidelines

Primary Treatment Recommendation

• The American Academy of Dermatology recommends calcipotriene plus betamethasone dipropionate gel for scalp psoriasis with Grade A evidence, demonstrating superior efficacy compared to either agent alone 1
• Approximately 69-74% of patients reach clear or almost clear status versus 27% with vehicle control in 52-week studies 1

Treatment Duration and Regimen

• Initial treatment with calcipotriene 0.005% plus betamethasone dipropionate 0.064% gel or suspension should be applied once daily for 4-8 weeks 1
• For pediatric patients ≥12 years, treatment with calcipotriene 0.005% plus betamethasone dipropionate 0.064% gel or suspension should be applied once daily for up to 8 weeks (Strength of Recommendation B) 2, 3

Critical Safety Considerations

• Never combine salicylic acid with vitamin D analogs simultaneously, as the acidic pH inactivates calcipotriene/calcipotriol and reduces effectiveness 4
• Limit vitamin D analog use to maximum 100g/week in adults to prevent hypercalcemia 4
• For adolescents, the label recommends a limit of 80g/week for the combination scalp formulation 2, 3

Pediatric Considerations

• For children ages 12 and older with scalp psoriasis, the combination calcipotriol/betamethasone dipropionate suspension is recommended with Level II evidence 2, 3
• 58% of pediatric patients achieved disease clearance based on Patient's Global Assessment 2, 3
• Pruritus decreased from 65% at initiation to 10% at trial end in pediatric patients 2

Common Pitfalls to Avoid

• Avoid prolonged continuous use of high-potency corticosteroids to prevent HPA axis suppression and skin atrophy 4
• Monitor vitamin D metabolites with calcipotriene/calcipotriol use, particularly in patients with disorders of calcium metabolism or renal disease 2, 3
• Do not exceed recommended weekly dosage limits: 50 g/wk/m² for calcipotriol and 100 g/wk/m² for calcipotriene 2, 3